Refractory celiac disease type 2: how to diagnose and treat?
Rev. Assoc. Med. Bras. (1992, Impr.)
;
67(2): 168-172, Feb. 2021. tab, graf
Article
Dans Anglais
| LILACS
| ID: biblio-1287807
ABSTRACT
SUMMARY Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Maladie coeliaque
Type d'étude:
Etude diagnostique
/
Étude pronostique
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Rev. Assoc. Med. Bras. (1992, Impr.)
Thème du journal:
EducaÆo em Sa£de
/
GestÆo do Conhecimento para a Pesquisa em Sa£de
/
Médicament
Année:
2021
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Universidade Federal de Ciências da Saúde de Porto Alegre/BR
/
Universidade de Caxias do Sul/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS